Personal tools

MCL coexpression mm9:1883: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!2.07e-17!75;UBERON:0001017!7.35e-17!73;UBERON:0002384!1.70e-12!46;UBERON:0002020!4.73e-12!34;UBERON:0004121!1.26e-11!95;UBERON:0000924!1.26e-11!95;UBERON:0006601!1.26e-11!95;UBERON:0000073!1.69e-10!54;UBERON:0001049!2.38e-09!52;UBERON:0005068!2.38e-09!52;UBERON:0006241!2.38e-09!52;UBERON:0007135!2.38e-09!52;UBERON:0003528!4.39e-09!29;UBERON:0002791!4.39e-09!29;UBERON:0001893!4.39e-09!29;UBERON:0002346!1.15e-08!64;UBERON:0003075!1.15e-08!64;UBERON:0007284!1.15e-08!64;UBERON:0002780!3.65e-08!39;UBERON:0001890!3.65e-08!39;UBERON:0006240!3.65e-08!39;UBERON:0003080!9.49e-08!40;UBERON:0002616!2.90e-07!46;UBERON:0002371!4.75e-07!16;UBERON:0000955!6.32e-07!47;UBERON:0006238!6.32e-07!47
|ontology_enrichment_uberon=UBERON:0001016!2.07e-17!75;UBERON:0001017!7.35e-17!73;UBERON:0002384!1.70e-12!46;UBERON:0002020!4.73e-12!34;UBERON:0004121!1.26e-11!95;UBERON:0000924!1.26e-11!95;UBERON:0006601!1.26e-11!95;UBERON:0000073!1.69e-10!54;UBERON:0001049!2.38e-09!52;UBERON:0005068!2.38e-09!52;UBERON:0006241!2.38e-09!52;UBERON:0007135!2.38e-09!52;UBERON:0003528!4.39e-09!29;UBERON:0002791!4.39e-09!29;UBERON:0001893!4.39e-09!29;UBERON:0002346!1.15e-08!64;UBERON:0003075!1.15e-08!64;UBERON:0007284!1.15e-08!64;UBERON:0002780!3.65e-08!39;UBERON:0001890!3.65e-08!39;UBERON:0006240!3.65e-08!39;UBERON:0003080!9.49e-08!40;UBERON:0002616!2.90e-07!46;UBERON:0002371!4.75e-07!16;UBERON:0000955!6.32e-07!47;UBERON:0006238!6.32e-07!47
|tfbs_overrepresentation_for_novel_motifs=1.54788,1.30284,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.993085,0.489964,0.755749,1.85721,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,0.503207,0.30022,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.544696,0.504971,0.0986756,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,1.40903,0.37865,1.04072,0.884013,0.362446,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.961641,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,1.41174,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.569254,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,1.069,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.0824127
}}
}}

Revision as of 20:34, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:14110901..14110902,+p@chr10:14110901..14110902
+
Mm9::chr13:49342840..49342841,+p@chr13:49342840..49342841
+
Mm9::chr2:173625553..173625555,+p@chr2:173625553..173625555
+
Mm9::chr9:83698949..83698950,-p@chr9:83698949..83698950
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
animal cell6.00e-37115
eukaryotic cell6.00e-37115
somatic cell3.32e-35118
somatic stem cell1.01e-2891
multi fate stem cell1.01e-2891
stem cell1.73e-2897
embryonic cell4.78e-2670
non-terminally differentiated cell4.21e-2549
neural cell2.36e-2443
ectodermal cell1.99e-2344
neurectodermal cell1.99e-2344
electrically responsive cell7.16e-1939
electrically active cell7.16e-1939
neuron3.40e-1833
neuronal stem cell3.40e-1833
neuroblast3.40e-1833
electrically signaling cell3.40e-1833
motile cell1.40e-1654
CNS neuron (sensu Vertebrata)1.73e-1423
neuroblast (sensu Vertebrata)1.73e-1423
connective tissue cell1.70e-1246
mesenchymal cell1.70e-1246
hematopoietic lineage restricted progenitor cell1.43e-1125
myeloid lineage restricted progenitor cell1.44e-0813
hematopoietic cell2.17e-0732
hematopoietic oligopotent progenitor cell2.17e-0732
hematopoietic stem cell2.17e-0732
angioblastic mesenchymal cell2.17e-0732
hematopoietic multipotent progenitor cell2.17e-0732
migratory neural crest cell5.67e-0710
neuron associated cell5.67e-0710
glial cell (sensu Vertebrata)5.67e-0710
neuron associated cell (sensu Vertebrata)5.67e-0710
glial cell5.67e-0710
glioblast5.67e-0710
glioblast (sensu Vertebrata)5.67e-0710
oligodendrocyte precursor cell9.01e-078

Uber Anatomy
Ontology termp-valuen
nervous system2.07e-1775
central nervous system7.35e-1773
connective tissue1.70e-1246
gray matter4.73e-1234
ectoderm-derived structure1.26e-1195
ectoderm1.26e-1195
presumptive ectoderm1.26e-1195
regional part of nervous system1.69e-1054
neural tube2.38e-0952
neural rod2.38e-0952
future spinal cord2.38e-0952
neural keel2.38e-0952
brain grey matter4.39e-0929
regional part of telencephalon4.39e-0929
telencephalon4.39e-0929
neurectoderm1.15e-0864
neural plate1.15e-0864
presumptive neural plate1.15e-0864
regional part of forebrain3.65e-0839
forebrain3.65e-0839
future forebrain3.65e-0839
anterior neural tube9.49e-0840
regional part of brain2.90e-0746
bone marrow4.75e-0716
brain6.32e-0747
future brain6.32e-0747


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}